Antiangiogenic agents: fueling cancer's hypoxic roots

Cell Cycle. 2012 Apr 1;11(7):1265-6. doi: 10.4161/cc.19890. Epub 2012 Apr 1.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors* / pharmacology
  • Angiogenesis Inhibitors* / therapeutic use
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Bevacizumab
  • Cell Hypoxia
  • Humans
  • Indoles / pharmacology
  • Indoles / therapeutic use
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Neoplastic Stem Cells / drug effects*
  • Neoplastic Stem Cells / pathology
  • Neovascularization, Pathologic / drug therapy*
  • Pyrroles / pharmacology
  • Pyrroles / therapeutic use
  • Sunitinib

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Indoles
  • Pyrroles
  • Bevacizumab
  • Sunitinib